Product
Bupivacaine Hydrochloride
8 clinical trials
17 indications
Indication
Postoperative PainIndication
AnesthesiaIndication
spinalIndication
PainIndication
PostoperativeIndication
AmputationIndication
AnalgesicIndication
Upper Extremity InjuryIndication
Liver CancerIndication
Chronic Postoperative PainIndication
Misoprostol AllergyIndication
Oxytocin AllergyIndication
Tranexamic AcidIndication
EthamsylateIndication
MyomaIndication
HemorrhageIndication
SurgeryClinical trial
A Phase 2B, Randomized, Double Blind, Active Comparator, Multicenter, Safety, and Efficacy Trial of ATX-101 in Subjects Undergoing Total Knee ArthroplastyStatus: Active (not recruiting), Estimated PCD: 2025-08-31
Clinical trial
The Maternal CLIMB Trial: Chloroprocaine to Reduce the Impact of Motor Block on Patient Recovery After Short Obstetric SurgeryStatus: , Estimated PCD: 2024-06-04
Clinical trial
A Prospective, Randomized Trial of Liposomal Bupivacaine Compared to Continuous Nerve Catheters on Pain Control and Post-Operative Opioid Use in Receiving Popliteal Nerve Blocks for Below the Knee AmputationStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Pharmacokinetic Analysis of Bupivacaine in the Presence and Absence of Perineural Dexamethasone in Axillary Brachial Plexus Blockade for Distal Forearm and Hand SurgeryStatus: Completed, Estimated PCD: 2023-04-17
Clinical trial
Thoracic Paravertebral Block With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone for Postoperative Analgesia in Patients Undergoing Liver ResectionStatus: Recruiting, Estimated PCD: 2024-05-29
Clinical trial
Prospective Randomized Study Comparing Suprainguinal Fascia Iliaca Block vs. Pericapsular Nerve Group Block vs. Local Anesthetic Infiltration vs. Spinal Anesthetic Without Adjuncts for Pain Control Following Total Hip ArthroplastyStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
UROLOGICAL SURGERIES IN CHILDREN: Comparison Between 0.25% Bupivacaine and 0.25% Bupivacaine withDexmedetomidine in the Caudal BlockStatus: Completed, Estimated PCD: 2021-11-15